INDICATION:
It is used in the management of hypertension, angina pectoris, cardiac arrhythmias, myocardial infraction and heart failure. It is also used in the management of hyperthyroidism and in prophylactic treatment of migraine.
INDICATION:
Carvedilol is used in the management of essential hypertension, congestive heart failure and angina pectoris.
INDICATION:
It is given prophylactically as an alternative to aspirin in patient at risk of thromboembolic disorders such as myocardial, peripheral arterial disease and stroke.
INDICATION:
Losartan potassium is used in the management of hypertension.
INDICATION:
It is used to reduce LDL-Cholesterol, apolipoprotein B, and triglycerides and to increase HDL-Cholesterol in the treatment of hyperlipidaemias (Type lla or llb hyperlipoproteinaemias), hypertriglyceridaemia (type IV) and dysbetalipoproteinaemia (type III).
INDICATION:
Used in angina pectoris and in ischaemia of neurosensorial tissue as in Meniere’s disease.
INDICATIONS:
Amiodarone HCI is mainly indicated in life-threatening recurrent ventricular arrhythmias, including arrhythmias associated with Wolff-Parkinson-White syndrome. It has been tried for the prevention of arrhythmias in patients with myocardial infraction or heart failure.
Amiodarone HCI is mainly indicated in life-threatening recurrent ventricular arrhythmias, including arrhythmias associated with Wolff-Parkinson-White syndrome. It has been tried for the prevention of arrhythmias in patients with myocardial infraction or heart failure.
INDICATIONS:
Glimepiride is used for the management of type 2 diabetes mellitus.
Glimepiride is used for the management of type 2 diabetes mellitus.
INDICATIONS:
Metformin hydrochloride is a biguanide hypoglycemic agent used in the treatment of Non-Insulin-Dependent Diabetes Mellitus.
INDICATIONS:
Gemfibrozil is used to reduce total cholesterol and triglycerides in the management of hyperlipidaemias, including type lla, type llb, type III, type IV and type V hyperlipoproteinaemias. It is also indicated for the primary prevention of ischaemic heart disease in hyperlipidaemic middle-aged men who have not responded to dietary and other measures.
Gemfibrozil is used to reduce total cholesterol and triglycerides in the management of hyperlipidaemias, including type lla, type llb, type III, type IV and type V hyperlipoproteinaemias. It is also indicated for the primary prevention of ischaemic heart disease in hyperlipidaemic middle-aged men who have not responded to dietary and other measures.
INDICATIONS:
•Management of all patients with type 1 diabetes
•Management of patients with type 2 diabetes who are not adequately controlled by diet and/or oral hypoglycaemic agents.
•For the initial stabilization of diabetes in patients with diabetes in patients with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and during periods of stress such as severe infections and major surgery in diabetic patients
•Management of gestational diabetes
•Management of all patients with type 1 diabetes
•Management of patients with type 2 diabetes who are not adequately controlled by diet and/or oral hypoglycaemic agents.
•For the initial stabilization of diabetes in patients with diabetes in patients with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and during periods of stress such as severe infections and major surgery in diabetic patients
•Management of gestational diabetes
INDICATIONS:
For the treatment of acute and chronic infections of the respiratory tract, genito-urinary tract, otitis media and other infections due to sensitive organisms.
For the treatment of acute and chronic infections of the respiratory tract, genito-urinary tract, otitis media and other infections due to sensitive organisms.
INDICATIONS:
For the treatment of infection of the lower and upper respiratory tract, gastrointestinal tract, genitourinary tract, skin and soft tissue infections and other infections caused by Gram-positive and Gram-negative organisms.
For the treatment of infection of the lower and upper respiratory tract, gastrointestinal tract, genitourinary tract, skin and soft tissue infections and other infections caused by Gram-positive and Gram-negative organisms.
INDICATIONS:
For the treatment of acute and chronic infections of the respiratory tract, genito-urinary tract, gastrointestinal tract, skin and soft tissue and other bacterial infections caused by sensitive organisms.
For the treatment of acute and chronic infections of the respiratory tract, genito-urinary tract, gastrointestinal tract, skin and soft tissue and other bacterial infections caused by sensitive organisms.
INDICATIONS:
For the treatment of lower and upper respiratory tract infections, genitourinary tract infections, skin and soft tissue infections and gonorrhea.
For the treatment of lower and upper respiratory tract infections, genitourinary tract infections, skin and soft tissue infections and gonorrhea.
INDICATIONS:
For the treatment of lower and upper respiratory tract infections, genitourinary tract infections, skin and soft tissue infections and gonorrhea.
For the treatment of lower and upper respiratory tract infections, genitourinary tract infections, skin and soft tissue infections and gonorrhea.
INDICATIONS:
It is used in the treatment of susceptible infections, including intra-abdominal infections, meningitis, respiratory tract infections (including cystic fibrosis patients) septicaemia, skin infections, urinary tract infections, and infections in immunocompromised patients.
It is used in the treatment of susceptible infections, including intra-abdominal infections, meningitis, respiratory tract infections (including cystic fibrosis patients) septicaemia, skin infections, urinary tract infections, and infections in immunocompromised patients.
INDICATIONS:
For the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the following conditions: Lower respiratory tract infections, complicated and uncomplicated urinary tract infections, intra-abdominal infections, skin and structure infections, bacterial septicemia and gynecological infections.
For the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the following conditions: Lower respiratory tract infections, complicated and uncomplicated urinary tract infections, intra-abdominal infections, skin and structure infections, bacterial septicemia and gynecological infections.
INDICATION:
Omeprazole use in conditions where inhibition of gastric acid secretion may be beneficial including aspiration syndromes, dyspepsia, gastro-esophageal reflux disease, peptic ulcer disease and the Zollinger-Ellison syndrome.
Used in benign gastric and duodenal ulcers, Zollinger-Ellison syndrome, gastric acid reduction, gastro-esophageal reflux disease, acid reflux disease and acid-related dyspepsia.
Omeprazole use in conditions where inhibition of gastric acid secretion may be beneficial including aspiration syndromes, dyspepsia, gastro-esophageal reflux disease, peptic ulcer disease and the Zollinger-Ellison syndrome.
Used in benign gastric and duodenal ulcers, Zollinger-Ellison syndrome, gastric acid reduction, gastro-esophageal reflux disease, acid reflux disease and acid-related dyspepsia.
INDICATION:
Treatement of duodenal and gastric ulcer, including that associated with H. pylori, NSAID-associated peptic ulcer, post-operative ulcer, acute reflux esophagitis, Zollinger-Ellison syndrome, chronic episodic dyspepsia, symptomatic relief in gastro-esophageal reflux disease and prophylaxis of Mendelson’s syndrome.
Treatement of duodenal and gastric ulcer, including that associated with H. pylori, NSAID-associated peptic ulcer, post-operative ulcer, acute reflux esophagitis, Zollinger-Ellison syndrome, chronic episodic dyspepsia, symptomatic relief in gastro-esophageal reflux disease and prophylaxis of Mendelson’s syndrome.
INDICATION:
Relief of mild to moderate pain arising from rheumatoid arthritis (including Still’s disease), soft tissue injuries, other painful musculo-skeletal conditions, headache, dental pain, post-operative pain and dysmenorrhea.
Relief of mild to moderate pain arising from rheumatoid arthritis (including Still’s disease), soft tissue injuries, other painful musculo-skeletal conditions, headache, dental pain, post-operative pain and dysmenorrhea.
INDICATION:
Used in the conditions where inhibition of gastric acid secretion may be beneficial, including aspiration syndromes, dyspepsia, gastroesophageal reflux disease, peptic ulcer disease and Zollinger-Ellison syndrome.
Used in the conditions where inhibition of gastric acid secretion may be beneficial, including aspiration syndromes, dyspepsia, gastroesophageal reflux disease, peptic ulcer disease and Zollinger-Ellison syndrome.
INDICATION:
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
It is used in the management of chronic asthma, allergic rhinitis, and as prophylaxis for exercise-induced asthma.
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
It is used in the management of chronic asthma, allergic rhinitis, and as prophylaxis for exercise-induced asthma.
INDICATION:
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
INDICATION:
For the relief of bronchial asthma, bronchitis, bronchospasm, emphysema, bronchiectasis and other obstructive pulmonary diseases where broncho-constriction is a complicating factor.
For the relief of bronchial asthma, bronchitis, bronchospasm, emphysema, bronchiectasis and other obstructive pulmonary diseases where broncho-constriction is a complicating factor.
INDICATION:
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
For the relief of bronchospasm in bronchial asthma, chronic bronchitis, bronchiectasis, emphysema and other reversible obstructive pulmonary disease.
INDICATION:
Sidenafil is a phosphodiesterase type-5 inhibitor used in the management of erectile dysfunction.
Sidenafil is a phosphodiesterase type-5 inhibitor used in the management of erectile dysfunction.